 - Failure to achieve any objective response CR - complete remission, PR - partial remissino, mCR - marrow complete remission, or HI - hematologic improvement, but no evidence of disease progression within the 8 weeks leading to the subjects first dose of IP INVESTIGATIONAL PRODUCT in this study Cycle 1, Day 1 